Compound Detail
CHEMBL3545376
ERDAFITINIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL3545376 |
| Name | ERDAFITINIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | OLAHOMJCDNXHFI-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
20
Targets
82
Activities
1
Assay Types
1
PK Parameters
20
Publications
3
Known Names
17
Indications
1
Mechanisms
Molecular Properties
446.6
MW (Da)
4.18
ALogP
8
HBA
1
HBD
77.3
PSA (Ų)
0.41
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2019 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Fibroblast growth factor receptor inhibitor | INHIBITOR | Fibroblast growth factor receptor | ✓ | ✓ |
Indications
Carcinoma, Transitional Cell Neoplasms Neoplasms Urinary Bladder Neoplasms Urinary Bladder Neoplasms Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Multiple Myeloma Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Breast Neoplasms Carcinoma, Hepatocellular Liver Diseases Lymphoma
ATC Classification
L01EN01
erdafitinib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 82 meas. best 10.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 CHEMBL3337 | IC50 | 10.0 | 10.0 | 0.1 | 1 |
| Fibroblast growth factor receptor 1 CHEMBL3650 | IC50 | 9.6 | 8.4089 | 0.2 | 9 |
| Fibroblast growth factor receptor 3 CHEMBL2742 | IC50 | 9.38 | 8.4971 | 0.4 | 14 |
| SNU-16 CHEMBL613529 | IC50 | 9.15 | 8.9567 | 0.7 | 3 |
| Unchecked CHEMBL612545 | IC50 | 8.96 | 8.2388 | 1.1 | 8 |
| RT-112 CHEMBL614145 | IC50 | 8.89 | 7.622 | 1.3 | 5 |
| Fibroblast growth factor receptor 2 CHEMBL4142 | IC50 | 8.82 | 8.3044 | 1.5 | 9 |
| Fibroblast growth factor receptor 4 CHEMBL3973 | IC50 | 8.7 | 8.2989 | 2.0 | 9 |
| KG-1 CHEMBL612264 | IC50 | 8.68 | 8.68 | 2.1 | 1 |
| CC-LP-1 CHEMBL6066762 | IC50 | 8.64 | 7.3725 | 2.3 | 4 |
| RT112/84 CHEMBL6066783 | IC50 | 8.44 | 7.055 | 3.6 | 2 |
| KATO III stomach cancer cell line CHEMBL612700 | IC50 | 8.4 | 8.4 | 4.0 | 1 |
| RT-4 CHEMBL614884 | IC50 | 8.36 | 8.36 | 4.4 | 1 |
| DMS-114 CHEMBL614642 | IC50 | 7.96 | 7.96 | 11.0 | 1 |
| A2780 CHEMBL614004 | IC50 | 7.7 | 7.7 | 20.0 | 2 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 7.43 | 7.018 | 36.8 | 5 |
| TEL/KDR CHEMBL4630759 | IC50 | 6.2 | 6.2 | 627.0 | 1 |
| K562 CHEMBL385 | IC50 | 5.52 | 5.52 | 3020.0 | 2 |
| HCT-116 CHEMBL394 | IC50 | 5.37 | 5.37 | 4240.0 | 2 |
| Jurkat CHEMBL397 | IC50 | 5.17 | 5.17 | 6810.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| t1/2 | - | - | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine